Delivery Order SPE2DB22D2103-SPE2DB25FR9TY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Risperidone 3 mg tablets in a quantity of 60 units, with a ceiling value of $1,816.53 and a firm fixed-price contract type. The order is not set-aside and represents a competitive award to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,169.30 by the Defense Logistics Agency on May 29, 2025, for the supply of Risperidone 0.5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of May 30, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement requirements...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.47 to AmerisourceBergen Drug Corp for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for 500 tablets of Risperidone 2 mg at a ceiling value of $3,458. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,275.84 to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a routine pharmaceutical supply transaction for federal medical operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9TYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical utilizes this contract vehicle to procure critical medications across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems, with AmerisourceBergen positioned as a key vendor for the agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/10/25 |